ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
45 announcements
Sonitron Limited, a promoter group entity, acquired 10,000 equity shares of Dhampur Bio Organics Limited through the open market. This acquisition increased the promoter's stake by 0.015%.
Promoter Group entity Sonitron Limited acquired 10,000 shares of Dhampur Bio Organics Ltd via market purchase for Rs.0.11 Crore, increasing their stake to 17.37%.
DBO Employee Welfare Trust bought 10,000 Dhampur Bio Organics shares on NSE for ₹0.11 Crore. Routine ESOP trust inventory purchase.
DBO Employee Welfare Trust acquired 20,000 equity shares of Dhampur Bio Organics Ltd via market purchase on September 17 and 18, 2026.
DBO Employee Welfare Trust purchased 25,000 equity shares via market route on September 15-16, 2026. The total consideration for these acquisitions is ₹0.29 Crore.
DBO Employee Welfare Trust acquired 5,000 equity shares of Dhampur Bio Organics Ltd via market purchase for Rs. 0.06 Crore.
DBO Employee Welfare Trust purchased 5,000 equity shares of Dhampur Bio Organics Ltd from the market for ₹0.07 Crore on September 3, 2026.
CARE Ratings has reaffirmed the credit rating for Dhampur Bio Organics Limited's bank facilities, assigning CARE BBB+ (Positive) for long-term and CARE A2 for short-term facilities.
Dhampur Bio Organics Ltd has remitted the final dividend of ₹1.50 per equity share for the financial year 2025-26 to its shareholders.
Sonitron Limited, a promoter group entity, acquired 40,000 equity shares of Dhampur Bio Organics Limited. The open-market purchase increased its total stake from 17.29% to 17.35%.
Mr. Lalit Dalal has resigned as Vice President - Finance & Accounts of Dhampur Bio Organics Ltd, effective from the close of business hours on July 31, 2026.
Sonitron Ltd increased its stake in Dhampur Bio Organics Ltd via open market purchases. The promoter holding rose from 17.27% to 17.29%.
Dhampur Bio Organics Limited held its 6th Annual General Meeting on July 24, 2026, to conduct business, including dividend declaration and various appointments.
Dhampur Bio Organics Limited's Board met to consider a dividend declaration. The Board decided not to declare any dividend at this time.
Dhampur Bio Organics reported Q1FY27 Revenue of ₹553.88 Cr (up 4.51% YoY) but a loss from continued operations of ₹12.14 Cr. Strategic focus is transitioning to value-added sugar, spirits, and bio-energy.
Dhampur Bio Organics re-appointed Grant Thornton Bharat LLP as Internal Auditor for 12 months. The decision was finalized during a board meeting on July 14, 2026.
Dhampur Bio Organics completed the acquisition of a 74% stake in DBION Private Limited for Rs. 74,000. DBION is now a subsidiary and joint venture entity.
Dhampur Bio Organics scheduled a board meeting for July 14, 2026. The board will consider Q1 results and a proposal for interim dividend declaration.
Dhampur Bio Organics released its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's ESG performance and operational disclosures.
Dhampur Bio Organics Ltd filed its FY 2025-26 Annual Report. The 6th AGM is slated for July 24, 2026.
Dhampur Bio Organics Ltd convenes its 6th AGM on July 24, 2026 via video conference. The meeting will declare a 15% final dividend of Rs 1.50 per share.
Dhampur Bio Organics Ltd announced the resignation of Vice President – Operations, Mr. Santosh Mani, effective June 30, 2026. The company filed the notice under SEBI Regulation 30.
Shudh Edible Products Private Ltd, a promoter, disclosed open‑market purchase of Dhampur Bio Organics Ltd shares. No monetary amount is disclosed.
Mrs. Monika Sharma resigned as VP - IT of Dhampur Bio Organics Ltd. Her departure is effective June 15, 2026, due to personal reasons.
Dhampur Bio Organics signed a Joint Venture Agreement with Orgonew Private Limited to develop bio-active food products. The company will hold a 74% majority stake.
Mr. Rakesh Agarwal has resigned as Vice President - Bottling Operations effective May 31, 2026. The departure from senior management is attributed to personal reasons.
Dhampur Bio Organics reported FY26 revenue of ₹2,082.01 Cr (up 10.57% YoY) and EBITDA of ₹162.01 Cr. Strategy focuses on value-added sugar and bio-energy transition.
Dhampur Bio Organics Limited redesignated Mr. Gautam Goel as Chairman and Chief Executive Officer effective May 31, 2026. This leadership realignment aims to streamline corporate governance.
Dhampur Bio Organics re-appointed Mittal Gupta & Company as Statutory Auditors for five years. The board also re-appointed Surendra Rai Kapur as Cost Auditor for FY 2026-27.
Dhampur Bio Organics recommended a final dividend of ₹0.15 per share for FY 2025-26. The record date is July 17, 2026, with payment expected by August 22.